Latest news
FDA Approves First Drug That Targets Root Cause of Narcolepsy, Opening New Era for Sleep Disorders - International Business Times, Singapore EditionInternational Business Times, Singapore Edition · Sat, 08 Aug 2026 03:55:01 GMTFDA approves Orzeyful, first drug to treat all symptoms of narcolepsy type 1 - Managed Healthcare ExecutiveManaged Healthcare Executive · Fri, 07 Aug 2026 20:06:51 GMTFDA Approves First mRNA-Based Seasonal Flu Vaccine for Adults Aged 50+ - Medical DialoguesMedical Dialogues · Fri, 07 Aug 2026 15:15:34 GMTFDA Approves First Narcolepsy Drug That Targets the Brain Signal Loss Behind the Disorder - Medical DailyMedical Daily · Fri, 07 Aug 2026 10:30:02 GMTFDA Approves Oveporexton, First Orexin Receptor Agonist for Narcolepsy Type 1 - Patient Care OnlinePatient Care Online · Fri, 07 Aug 2026 06:16:23 GMTTakeda (TAK) Wins FDA Approval For First-In-Class Narcolepsy Drug Orzeyful With $2–3 Billion Peak Sales Target - londoninsider.co.uklondoninsider.co.uk · Fri, 07 Aug 2026 05:51:01 GMTFDA Approves First Orexin-Targeting Therapy for Narcolepsy Type 1 - Medical DialoguesMedical Dialogues · Fri, 07 Aug 2026 02:30:09 GMTFDA approves first drug for full range of narcolepsy symptoms - Medical XpressMedical Xpress · Thu, 06 Aug 2026 22:00:03 GMT